Fragment-based design, synthesis and biological evaluation of theophylline derivatives as ATAD2 inhibitors in BT-549 cells

References

• Clapier CR, Iwasa J, Cairns BR, Peterson CL. Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes. Nat Rev Mol Cell Biol. 2017;18(7):407–422.
   PubMed Web of Science ®Google Scholar
• Revenko AS, Kalashnikova EV, Gemo AT, Zou JX, Chen HW. Chromatin loading of E2f-Mll complex by cancer-associated coregulator ANCCA via reading a specific histone mark. Mol Cell Biol. 2010;30(22):5260–5272.
   PubMed Web of Science ®Google Scholar
• Fu J, Zhang J, Chen X, Liu Z, Yang X, He Z, Hao Y, Liu B, Yao D. ATPase family AAA domain-containing protein 2 (ATAD2): from an epigenetic modulator to cancer therapeutic target. Theranostics. 2023;13(2):787–809.
   PubMed Web of Science ®Google Scholar
• Duan Z, Andrews NP, Chen CZ, Fan M, Wang J, Shen J, Li JJ, Chen HW. Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNA‑damaging chemotherapy agents and radiation. Oncol Rep. 2020;43(1):318–327.
   PubMed Web of Science ®Google Scholar
• Boussouar F, Jamshidikia M, Morozumi Y, Rousseaux S, Khochbin S. Malignant genome reprogramming by ATAD2. Biochim Biophys Acta. 2013;1829(10):1010–1014.
   PubMed Web of Science ®Google Scholar
• Baggiolini A, Callahan SJ, Montal E, Weiss JM, Trieu T, Tagore MM, Tischfield SE, Walsh RM, Suresh S, Fan Y, et al. Developmental chromatin programs determine oncogenic competence in melanoma. Science. 2021;373(6559):eabc1048.
   PubMed Web of Science ®Google Scholar
• Liu Q, Liu H, Huang X, Fan X, Xiao Z, Yan R, Yao J, An G, Ge Y, Miao J, et al. A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer. Cancer Gene Ther. 2023;30(1):192–208.
   PubMed Web of Science ®Google Scholar
• Yao D, Zhang J, Wang J, Pan D, He Z. Discovery of novel ATAD2 bromodomain inhibitors that trigger apoptosis and autophagy in breast cells by structure-based virtual screening. J Enzyme Inhib Med Chem. 2020;35(1):713–725.
   PubMed Web of Science ®Google Scholar
• Bamborough P, Chung CW, Demont EH, Bridges AM, Craggs PD, Dixon DP, Francis P, Furze RC, Grandi P, Jones EJ, et al. A qualified success: discovery of a new series of ATAD2 bromodomain inhibitors with a novel binding mode using high-throughput screening and hit qualification. J Med Chem. 2019;62(16):7506–7525.
   PubMed Web of Science ®Google Scholar
• Lucas SCC, Atkinson SJ, Bamborough P, Barnett H, Chung CW, Gordon L, Mitchell DJ, Phillipou A, Prinjha RK, Sheppard RJ, et al. Optimization of potent ATAD2 and CECR2 bromodomain inhibitors with an atypical binding mode. J Med Chem. 2020;63(10):5212–5241.
   PubMed Web of Science ®Google Scholar
• Bamborough P, Chung CW, Demont EH, Furze RC, Bannister AJ, Che KH, Diallo H, Douault C, Grandi P, Kouzarides T, et al. A chemical probe for the ATAD2 bromodomain. Angew Chem Int Ed Engl. 2016;55(38):11382–11386.
   PubMed Web of Science ®Google Scholar
• Winter-Holt JJ, Bardelle C, Chiarparin E, Dale IL, Davey PRJ, Davies NL, Denz C, Fillery SM, Guerot CM, Han F, et al. Discovery of a potent and selective ATAD2 bromodomain inhibitor with antiproliferative activity in breast cancer models. J Med Chem. 2022;65(4):3306–3331.
   PubMed Web of Science ®Google Scholar
• Fernandez-Montalvan AE, Berger M, Kuropka B, Koo SJ, Badock V, Weiske J, Puetter V, Holton SJ, Stockigt D, Ter Laak A, et al. Isoform-selective ATAD2 chemical probe with novel chemical structure and unusual mode of action. ACS Chem Biol. 2017;12(11):2730–2736.
   PubMed Web of Science ®Google Scholar
• Murray BW, Guo C, Piraino J, Westwick JK, Zhang C, Lamerdin J, Dagostino E, Knighton D, Loi CM, Zager M, et al. Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proc Natl Acad Sci U S A. 2010;107(20):9446–9451.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zou L, Tang P, Pan D, He Z, Yao D. Design, synthesis and biological evaluation of 1H-pyrazolo [3,4-d]pyrimidine derivatives as PAK1 inhibitors that trigger apoptosis, er stress and anti-migration effect in MDA-MB-231 cells. Eur J Med Chem. 2020;194(:112220.
   PubMed Web of Science ®Google Scholar
• Harner MJ, Chauder BA, Phan J, Fesik SW. Fragment-based screening of the bromodomain of ATAD2. J Med Chem. 2014;57(22):9687–9692.
   PubMed Web of Science ®Google Scholar
• Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22–35.
   PubMed Web of Science ®Google Scholar
• Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The Myc oncogene – the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19(1):23–36.
   PubMed Web of Science ®Google Scholar
• Zimmerli D, Brambillasca CS, Talens F, Bhin J, Linstra R, Romanens L, Bhattacharya A, Joosten SEP, Da Silva AM, Padrao N, et al. Myc promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling. Nat Commun. 2022;13(1):6579.
   PubMed Web of Science ®Google Scholar
• Wang W, Liao P, Shen M, Chen T, Chen Y, Li Y, Lin X, Ge X, Wang P. SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62. Oncogene. 2016;35(4):491–500.
   PubMed Web of Science ®Google Scholar
• Ciro M, Prosperini E, Quarto M, Grazini U, Walfridsson J, McBlane F, Nucifero P, Pacchiana G, Capra M, Christensen J, et al. ATAD2 is a novel cofactor for Myc, overexpressed and amplified in aggressive tumors. Cancer Res. 2009;69(21):8491–8498.
   PubMed Web of Science ®Google Scholar
• Fouret R, Laffaire J, Hofman P, Beau-Faller M, Mazieres J, Validire P, Girard P, Camilleri-Broet S, Vaylet F, Leroy-Ladurie F, et al. A comparative and integrative approach identifies ATPase family, AAA domain containing 2 as a likely driver of cell proliferation in lung adenocarcinoma. Clin Cancer Res. 2012;18(20):5606–5616.
   PubMed Web of Science ®Google Scholar
• Wang AQ, Lv M, Xu YH, Xie PM, Dong YY. MiR-200b-5p inhibits proliferation of ovarian cancer cells by targeting ATAD2 and regulating PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci. 2020; 24(19):9860–9868.
   PubMed Web of Science ®Google Scholar
• Yi SA, Zhang Y, Rathnam C, Pongkulapa T, Lee KB. Bioengineering approaches for the advanced organoid research. Adv Mater. 2021;33(45):e2007949.
   PubMed Web of Science ®Google Scholar
• Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev. 2017;277(1):76–89.
   PubMed Web of Science ®Google Scholar
• Case DA, Cheatham TE III, Darden T, Gohlke H, Luo R, Merz KM Jr, Onufriev A, Simmerling C, Wang B, Woods RJ. The amber biomolecular simulation programs. J Comput Chem. 2005;26(16):1668–1688.
   PubMed Web of Science ®Google Scholar
• Yao D, Pan D, Zhen Y, Huang J, Wang J, Zhang J, He Z. Ferulin c triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting tubulin polymerization in vitro and in vivo. Pharmacol Res. 2020;152:104605.
   PubMed Web of Science ®Google Scholar